Verrica Pharmaceuticals (VRCA) Stock Chart & Stock Price History $4.23 +0.13 (+3.17%) Closing price 04:00 PM EasternExtended Trading$4.10 -0.13 (-3.05%) As of 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Verrica Pharmaceuticals Stock Price Performance The Verrica Pharmaceuticals (VRCA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 72.52%, with a year-to-date return of -40.71%. In the past month, the stock has decreased 5.90%, reflecting recent market activity. As of the latest close, Verrica Pharmaceuticals traded at $4.10 with a market cap of $38.75 million and volume of 58,211 shares. Five years ago, the stock traded at a split-adjusted price of $86.90, representing a 95.22% decrease over that period. At the time, it had a market cap of $224.33 million and a volume of 5,064 shares. Receive VRCA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.24%1 Month Performance-5.90%3 Month Performance-50.55%Year-To-Date Performance-40.71%1 Year Performance-72.52%5 Year Performance-95.22% VRCA Stock Chart for Thursday, October, 16, 2025 VRCA Chart by TradingView Verrica Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$4.11$4.10-0.24%$4.15$3.9758,211 shs$38.75 million10/14/2025$4.10$4.11+0.24%$4.15$3.9566,024 shs$38.84 million10/13/2025$4.14$4.10-0.97%$4.26$3.9773,043 shs$38.73 million10/10/2025$4.30$4.14-3.72%$4.36$4.10114,870 shs$39.11 million10/09/2025$4.42$4.30-2.71%$4.85$4.09190,316 shs$40.64 million10/08/2025$4.61$4.42-4.12%$4.58$4.26267,619 shs$41.77 million10/07/2025$4.69$4.61-1.71%$4.73$4.462.19 million shs$43.55 million10/06/2025$4.67$4.69+0.43%$4.75$4.4758,585 shs$44.32 million10/03/2025$4.54$4.67+2.86%$4.72$4.4756,409 shs$44.13 million10/02/2025$4.44$4.54+2.25%$4.55$4.3164,975 shs$42.90 million Get the Latest News and Ratings for VRCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$4.31$4.44+3.02%$4.49$4.2447,312 shs$41.94 million09/30/2025$4.30$4.31+0.23%$4.36$4.1719,833 shs$40.73 million09/29/2025$4.18$4.30+2.87%$4.39$4.2158,103 shs$40.64 million09/26/2025$4.09$4.18+2.20%$4.31$4.0042,891 shs$39.50 million09/25/2025$4.17$4.09-1.92%$4.40$4.0160,870 shs$38.63 million09/24/2025$4.31$4.17-3.25%$4.33$4.00154,874 shs$39.41 million09/23/2025$4.46$4.31-3.36%$4.55$4.2491,659 shs$40.73 million09/22/2025$4.39$4.46+1.59%$4.50$4.15270,634 shs$42.13 million09/19/2025$4.04$4.39+8.66%$4.90$4.138.11 million shs$41.47 million09/18/2025$4.41$4.04-8.39%$4.62$3.96131,781 shs$38.18 million09/17/2025$4.41$4.41$4.84$4.3756,167 shs$41.67 million09/16/2025$4.94$4.41-10.73%$5.17$4.35118,346 shs$41.66 million09/15/2025$4.75$4.94+4.00%$5.23$4.7390,196 shs$46.68 million Related Companies AVTX Stock Price Chart SAVA Stock Price Chart ELDN Stock Price Chart PEPG Stock Price Chart GNLX Stock Price Chart IXHL Stock Price Chart ACTU Stock Price Chart CCCC Stock Price Chart PYXS Stock Price Chart CTOR Stock Price Chart Receive VRCA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRCA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verrica Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
